Sandoz signs 10-year agreement with partner Delpharm, a global pharmaceutical developer and contract manufacturerAgreement will secure a reliable ...

After getting its hands on a massive Quebecois manufacturing plant from Sandoz in 2022, French CDMO Delpharm is making good ...

Twenty U.S. states including California, Connecticut and Michigan have pushed back against a $10 million settlement that Florida reached with Swiss generic drugmaker Sandoz, saying a key provision ...

Sandoz reported a 9% growth in net sales of generics and biosimilars to third parties for 2024, marking a strong first financial year as an independent company. After completing its spin-off from ...

Swiss generics and biosimilars giant Sandoz today announced financial results for the full year 2024, showing that sales were ...

SteinCares serves as a bridge between pharmaceutical companies ... to market with many biosimilars and generic products, we were selected by Sandoz to do this transaction in Colombia,” he ...

Sandoz garners chunky demand for 10 year trade ◆ Trend continues for issuers to set deal parameters quickly ◆ Single digit ...

Skincare product maker Galderma, and pharmaceutical company Sandoz both returned to their home market this week, bringing ...

Melbourne: Avecho Biotechnology Limited has announced it has signed an exclusive ten-year development and licensing agreement ...

Sandoz signs 10-year agreement with partner Delpharm, a global pharmaceutical developer and contract manufacturer Agreement will secure a reliable supply of affordable, quality sterile injectables ...